NCPA, NACDS Statement on Drug Pricing Rule’s Failure to Reform Pharmacy DIR

By |2019-05-16T17:56:09-04:00May-16-19|Categories: Press Release|Tags: , , |

NCPA and NACDS: "We are disappointed and frustrated that this final rule fails to finalize pharmacy DIR reform as proposed, to the detriment of seniors and community pharmacies. Our organizations have been joined by many pharmacists, pharmacy stakeholder groups, patient advocacy organizations, patients, and members of Congress in advocating that all pharmacy price concessions be included at the point of sale – or eliminated altogether – to provide senior patients with lower costs and pharmacies with more certainty..."

Pharmacy Groups Join in Support of CMS’ Rejection of Below-Cost Medicaid Dispensing Fees in Washington State Washington State’s inaccurate justification for reimbursing pharmacies below cost—lower than any state in the country—threatens patient access to care

By |2019-03-18T14:43:27-04:00Mar-18-19|Categories: Press Release|Tags: , , |

Washington State’s inaccurate justification for reimbursing pharmacies below cost—lower than any state in the country—threatens patient access to care.

As HHS’ Azar Testifies, NACDS Urges His DIR Reform Proposals NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement

By |2019-03-14T11:16:45-04:00Mar-14-19|Categories: Press Release|Tags: , , , , , |

NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement.

NACDS Urges DIR Fee Reform in Morning Consult Op-Ed NACDS President & CEO Steven C. Anderson emphasizes DIR fee reform’s role in lowering patients’ out of pocket costs, reducing overall healthcare costs

By |2019-03-08T22:58:39-04:00Mar-08-19|Categories: Press Release|Tags: , , , , , |

Morning Consult today published an opinion piece by the NACDS entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.”

NACDS Urges DIR Fee Reform in Statement to House Ways and Means Committee Details opportunities to reduce patients’ out-of-pocket drug costs and to lower overall healthcare spending through DIR fee reform; Describes public’s trust of pharmacies’ cost-saving proposals

By |2019-02-12T17:07:13-04:00Feb-12-19|Categories: Press Release|Tags: , , , , |

NACDS today submitted a statement to the U.S. House of Representatives Committee on Ways and Means for the hearing titled “The Cost of Rising Prescription Drug Prices.”

NACDS, NCPA Thank Patient, Consumer Groups for Taking Important Stance on DIR Fee Reform Groups emphasize DIR fee reform’s power to reduce out-of-pocket drug costs and to reduce overall healthcare costs as a result of medication adherence and better health

By |2019-02-12T17:08:10-04:00Feb-12-19|Categories: Press Release|Tags: , , , , |

NACDS and the National Community Pharmacists Association (NCPA) today lauded 24 patient and consumer groups for advocating for pharmacy direct and indirect remuneration (DIR) fee reform.

Load More Posts